HIROTSU Bio Science is a cutting-edge brand in the field of nematode cancer testing. They contribute to the early detection of cancer through their advanced nematode behavioral analysis technology and clinical research achievements. While various types of cancer tests exist, such as PET-CT, ultrasound, MRI, CT, and the big five cancer tests, there is currently no affordable, simple, and highly accurate initial cancer test available.

However, N-NOSE, the nematode cancer test developed by HIROTSU Bio Science, meets all these criteria. HIROTSU Bio Science is the world's first biotechnology company dedicated to early cancer detection and has signed a memorandum of understanding with the Global Health Equity Fund, established by the WHO Foundation, to expand their overseas presence. With their unique testing technology harnessing the power of biology, HIROTSU Bio Science strives to protect people's health and future peace of mind.

Join them in their mission to make a difference!